REPLReplimune Group, Inc.May 22, 2025Q4 2025
Read transcript →Replimune Group, Inc. (REPL) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$14.98
+15.08%
Mkt Cap $1.23B
REPLReplimune Group, Inc.May 22, 2025REPLReplimune Group, Inc.May 22, 2025